There are many nuances that contribute to the complexity and duration of the research process I introduced back in October, 2024. Therefore, I wanted to take time each month to explore some of those nuances and how they factor into Open Medicine Foundation (OMF) research programs, starting at the beginning of the process with “Study Design”.
One important aspect of designing a study is determining the number of participants that will be included. It’s a difficult balance between trying to design a study with the best odds of producing an impactful result and working within the resources available.
At OMF, we try to use our resources wisely, focusing on scientifically rigorous research that has the potential to guide future research and patient care as quickly as possible. Conducting well-powered research is a big part of that mission, so I want to explain a little bit about what that means from a science perspective and how it impacted the design of our first clinical trial.
OMF aims to support well-powered research studies designed to:
“Well-powered” is a statistical way of saying that the study has enough data to indicate that any result discovered is unlikely to be due to chance. Typically, this is accomplished by increasing the sample size – the more participants showing the same result, the more likely the result is due to the thing being studied.
You can also consider the term well-powered as a way to describe a set of measurements. Take a clinical trial, for example. The set of measurements would be your primary outcomes (e.g., a set of surveys) and whether they are well-powered or not is impacted by the number of statistical tests being run on them. The more statistical tests done, the lower the power.
Typically, during the design phase of the research process, researchers will conduct what’s called a power analysis to help them calculate the sample size needed to see the desired effect. There are a lot of factors that go into a power analysis, but some of the main ones include:
To make this concept a little more tangible, let’s use the Life Improvement Trial (LIFT) as an example. Because of the complexity of studying the effect of multiple drugs in one trial, the LIFT will use a statistical model that accounts for data with multiple timepoints and subgroups. The LIFT significance level is set at p<0.05. Given these factors, a power analysis determined that 40 participants per study arm (160 participants total) will allow us to detect both large and medium effect sizes, which we hope will correlate with clinically meaningful changes.
First and foremost, look at the number of participants included in each group in the study, sometimes reported as an “n” – an n of 20 means there are 20 participants in that group. While there are many factors that go into power analyses, as a general rule of thumb, if there are fewer than 15 participants in each group, the study is likely under-powered. Under-powered studies may still provide useful information, but it’s important that the results are validated with larger, more robust studies before they are used to influence clinical action.
OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the extent allowed by law.
Open Medicine Foundation®
29302 Laro Drive, Agoura Hills, CA 91301 USA
Phone: 650-242-8669
info@omf.ngo
Copyright © 2025 Open Medicine Foundation. All Rights Reserved.
What are the advantages of giving from your Donor Advised Fund (DAF)?
How do I make a donation through my DAF?
Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.
Still can’t find your fund?
Gifting of Stock
Broker: Schwab
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then email or call OMF at 650-242-8669 to notify us of your donation or with any questions.